Literature DB >> 1948240

Octreotide-induced acute pancreatitis in a patient with acquired immunodeficiency syndrome.

J D Gradon1, R H Schulman, E K Chapnick, D V Sepkowitz.   

Abstract

Unremitting diarrhea is a common problem in patients with AIDS. We have reported the case of such a patient who was treated with the somatostatin analogue octreotide for chronic diarrhea and who had acute pancreatitis as a consequence of this therapy. We postulate that the possible mechanism for the pathogenesis of this pancreatic damage was octreotide-induced prevention of pancreatic exocrine secretion. We believe this acted as a "physiologic gallstone", inducing an attack of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1948240     DOI: 10.1097/00007611-199111000-00035

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Lanreotide autogel is a therapeutic option for patients who develop acute pancreatitis after somatostatin analog treatment.

Authors:  E Boix; P López; M Pérez-Mateo; A Picó
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 2.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

3.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.